Sara Lonardi

96PUBLICATIONS
508CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (96)

|Jul 24, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.

|Jun 26, 2026
Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

|Jun 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

|May 29, 2026
Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohort.

|Apr 27, 2026
Real-World Treatment Pathways of Adult Patients with Glioblastoma and Other CNS Tumors: A Population-Based Registry Study.

|Apr 25, 2026
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer.

Pageof 16

Frequent Collaborators

37 joint publications

Filippo Pietrantonio

25 joint publications

Chiara Cremolini

16 joint publications

Francesca Bergamo

11 joint publications

Thierry André